James B. McMahon
26Patents
7h-index
53Co-inventors
72Inventor score
Filing activity: Jan 29, 1993 → Feb 9, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5821081A | Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides | Human Necessities | 16 | Expired |
| US5843882A | Antiviral proteins and peptides | Human Necessities | 15 | Expired |
| US8067530B2 | Scytovirin domain 1 related polypeptides | Chemistry; Metallurgy | 11 | Active |
| US6245737A | Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins | Human Necessities | 11 | Expired |
| US5783598A | Antiretroviral naphthoquinone compounds compositions and uses thereof | Chemistry; Metallurgy | 10 | Expired |
| US5591770A | Calanolide and related antiretroviral compounds, compositions, and uses thereof | Chemistry; Metallurgy | 7 | Expired |
| US5869522A | Antiviral naphthoquinone compounds, compositions and uses thereof | Chemistry; Metallurgy | 7 | Expired |
| US8088729B2 | Anti-viral griffithsin compounds, compositions and methods of use | Human Necessities | 6 | Active |
| US5599839A | Antiviral composition | Human Necessities | 5 | Expired |
| US5859049A | Calanolide and related antiviral compounds, compositions, and uses thereof | Chemistry; Metallurgy | 4 | Expired |
| US5455251A | Michellamine antiviral agents, compositions, and treatment methods | Chemistry; Metallurgy | 4 | Expired |
| US5654432A | Process of preparing michellamine compounds | Chemistry; Metallurgy | 4 | Expired |
| US5998587A | Anti-cyanovirin antibody | Human Necessities | 4 | Expired |
| US6987096B1 | Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof | Chemistry; Metallurgy | 3 | Expired |
| US5672607A | Antiviral naphthoquinone compounds, compositions and uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US8481255B2 | Scytovirin domain 1 related polypeptides | Chemistry; Metallurgy | 0 | Active |
| US8729053B2 | Nuclear factor kappa B pathway inhibitor composition and use of same | Human Necessities | 0 | Active |
| US11034736B2 | Anti-viral cnidarins | Human Necessities | 0 | Active |
| US6673830B2 | Calanolide and related antiviral compounds, compositions, and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US9314448B2 | Method of inhibiting ABCG2 and other treatment methods | Chemistry; Metallurgy | 0 | Active |
| US10246463B2 | Hypoxia-inducible factor 1 (HIF-1) inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9114102B2 | Method of inhibiting ABCG2 and related treatments | Human Necessities | 0 | Active |
| US9937217B2 | Method of inhibiting ABCG2 and related treatments | Human Necessities | 0 | Active |
| US10849912B2 | Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US6774141B1 | Calanolide and related antiviral compounds, compositions, and uses thereof | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.